{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/gastroenteritis/management/adult-gastroenteritis/","result":{"pageContext":{"chapter":{"id":"97ae699a-60c4-5649-a4ad-f0bbdf5c7aa5","slug":"adult-gastroenteritis","fullItemName":"Scenario: Adult gastroenteritis","depth":2,"htmlHeader":"<!-- begin field 10d57975-a192-44d0-b341-6cbab2b2e0e4 --><h2>Scenario: Adult gastroenteritis</h2><!-- end field 10d57975-a192-44d0-b341-6cbab2b2e0e4 -->","summary":"Covers the management of adults with suspected gastroenteritis in primary care.","htmlStringContent":"<!-- begin item b2fbcb77-3a66-4ec8-a30d-0fe7238ed460 --><!-- begin field e0f63ee3-e217-48e9-8014-acbc015b7386 --><p>From age 16 years onwards.</p><!-- end field e0f63ee3-e217-48e9-8014-acbc015b7386 --><!-- end item b2fbcb77-3a66-4ec8-a30d-0fe7238ed460 -->","topic":{"id":"b4861e4a-0cf5-5fed-b83a-a57e60b78a80","topicId":"f3241704-6943-4c6f-9689-cf06812d0832","topicName":"Gastroenteritis","slug":"gastroenteritis","lastRevised":"Last revised in August 2020","chapters":[{"id":"6d884ff2-d64b-55ab-aae4-78f940a95f30","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"2b8c6f38-638e-5804-8318-e1b14304e522","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"94101b20-12cb-5041-a413-6dcc12af895e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"f4287eb4-029e-5263-ae00-6b8ece9aff32","slug":"changes","fullItemName":"Changes"},{"id":"4d578aaa-9662-5914-903d-e36514be32a0","slug":"update","fullItemName":"Update"}]},{"id":"d01dac38-120c-51d7-a620-b85d40b1eb15","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"cd1552a6-5a2d-563b-a242-29bd94992517","slug":"goals","fullItemName":"Goals"},{"id":"b7b0c03c-8588-5565-82d9-9cfe2d111d41","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b32a632a-610d-59de-bf5f-d79f466a66b7","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"28e54d5a-177d-5e18-9753-67134efb41a6","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"2b2f62eb-7996-5b9c-88ed-3648b2e3721d","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"1e2a0d5e-dba9-54fe-99e1-1e33dd814faa","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d382f491-ad27-5dbc-bfa7-806501a73eb5","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"c6b1334e-cda3-5363-a887-f24bcde0b626","slug":"definition","fullItemName":"Definition"},{"id":"501c659b-1656-5ad1-b381-f3042ed81bec","slug":"causes","fullItemName":"Causes"},{"id":"2e6d28a0-305f-5c3c-983a-62e1631c41b8","slug":"complications","fullItemName":"Complications"}]},{"id":"71e06d5f-9179-5a88-986f-34fd82eab600","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"de24a8b0-cda2-5be8-8fbf-df6ddf6fb6eb","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"3f17076e-616a-532c-a5ee-d6a5d2104dc5","slug":"assessment","fullItemName":"Assessment"},{"id":"bf8cbeb8-b0a5-5ebc-9cfc-7ba3beb62c6b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"34db7d00-7fa0-5e11-a2b2-0e045c80e236","fullItemName":"Management","slug":"management","subChapters":[{"id":"64ea9cd1-ae9b-5d77-bc7b-1df0c42b3d66","slug":"child-gastroenteritis","fullItemName":"Scenario: Child gastroenteritis"},{"id":"97ae699a-60c4-5649-a4ad-f0bbdf5c7aa5","slug":"adult-gastroenteritis","fullItemName":"Scenario: Adult gastroenteritis"}]},{"id":"3874a053-755a-5518-961d-b6811d36d278","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a6969159-fdcf-5f1f-ac9a-c8bcf291abdc","slug":"tinidazole","fullItemName":"Tinidazole"},{"id":"ddc9423c-8dd0-5c5b-b208-f261c2cd777d","slug":"clarithromycin","fullItemName":"Clarithromycin"}]},{"id":"84f507dc-726d-559a-b788-9c91297b0fd0","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"2e6aa3b5-4c48-538f-bc1e-8c97a0e4940e","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"60c6fc26-4bfa-5e0d-bba6-0ebffc61d83b","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0cb4826a-19bb-549f-b65f-2f5ad75883bc","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b05f7822-56ab-538c-9fb0-fd20a99810a2","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8bc3886a-0fd7-52a0-9be2-506de8584bc9","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a0898f71-226b-5af6-87b5-20b9c6c1fe78","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a52fa5fd-99e9-5dd5-b626-0e429b2424e3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"34db7d00-7fa0-5e11-a2b2-0e045c80e236","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"5d9c7087-f36a-5596-9b48-e38b290db0d8","slug":"hospital-admission","fullItemName":"Hospital admission","depth":3,"htmlHeader":"<!-- begin field 661f9971-0a30-49ce-8c42-0dc2131f91a8 --><h3>When should I admit an adult with gastroenteritis?</h3><!-- end field 661f9971-0a30-49ce-8c42-0dc2131f91a8 -->","summary":null,"htmlStringContent":"<!-- begin item 7799ddb2-4576-472f-8f5c-cde813f67ad2 --><!-- begin field 58e4811d-f853-441e-96a4-f75c2ddf6e74 --><p><strong>If an adult presents with <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/diagnosis/diagnosis/\">suspected</a> gastroenteritis:</strong></p><ul><li><strong>Arrange emergency hospital admission if:</strong><ul><li>The person is systemically unwell and/or there are clinical features suggesting <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/diagnosis/assessment/#assessing-for-dehydration-in-adults\">severe dehydration</a> and/or progression to shock.</li><li>There is intractable vomiting or high-output diarrhoea.</li><li>There is a suspected serious <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/complications/\">complication</a>, such as sepsis.</li></ul></li><li><strong>Consider arranging hospital assessment, the urgency depending on clinical judgement, if:</strong><ul><li>There are clinical features suggesting a potentially life-threatening or serious <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/diagnosis/differential-diagnosis/\">alternative diagnosis</a>.</li><li>There is an inadequate response to oral rehydration salt <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/management/adult-gastroenteritis/#management-in-primary-care\">(ORS) solution</a>, the person is unable to take ORS solution orally, or they are clinically deteriorating.</li><li>There are risk factors for developing dehydration, such as in the elderly, immunocompromised, those with co-morbid conditions or concurrent illness.</li><li>The person/carers are unable to provide appropriate management safely at home.</li></ul></li><li><strong>Liaise with a microbiologist or consultant in communicable disease control if:</strong><ul><li>There is uncertainty about the need for admission in a person with a <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/management/adult-gastroenteritis/#management-of-confirmed-cause\">confirmed microbiological cause</a> on stool culture and sensitivity testing.</li><li>There is uncertainty about the need for management in a person with moderate or severe suspected <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/definition/\">travellers' diarrhoea</a>.</li></ul></li></ul><!-- end field 58e4811d-f853-441e-96a4-f75c2ddf6e74 --><!-- end item 7799ddb2-4576-472f-8f5c-cde813f67ad2 -->","subChapters":[{"id":"24fbc6a9-050a-5601-bdaa-61429b43b090","slug":"basis-for-recommendation-ebb","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 66f94258-8652-4189-b66c-888dd7f1c1bf --><h4>Basis for recommendation</h4><!-- end field 66f94258-8652-4189-b66c-888dd7f1c1bf -->","summary":null,"htmlStringContent":"<!-- begin item ebbcc789-2a0b-4719-89fe-703ac75daaac --><!-- begin field 44c74096-6d57-4e14-904f-c6391070ca3e --><p>The recommendations on hospital assessment are largely based on or extrapolated from the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Diarrhoea and vomiting caused by gastroenteritis: diagnosis, assessment, and management in children younger than 5 years </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">National Collaborating Centre for Women's and Children's Health, 2009</a>]; the Public Health England (PHE) publications <em>Managing suspected infectious diarrhoea. Quick reference guidance for primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2015</a>] and <em>Recommendations for the public health management of gastrointestinal infections 2019. Principles and practice </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020a</a>]; the joint European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)/European Society for Pediatric Infectious Diseases (ESPID) publication <em>Evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Guarino, 2014</a>]; the Infectious Diseases Society of America (IDSA) publication <em>Clinical practice guidelines for the diagnosis and management of infectious diarrhea</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Shane, 2017</a>]; the World Gastroenterology Organisation (WGO) global guidelines <em>Acute diarrhea in adults and children: a global perspective</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>]; the expert consensus publication <em>Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Riddle, 2017</a>]; and expert opinion in a review article on acute diarrhoea in adults [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Jones, 2009</a>] and travellers' diarrhoea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Barrett, 2016</a>].</p><h5>Arranging emergency hospital admission</h5><ul><li>The recommendation if the person is systemically unwell, severely dehydrated, or shocked, is extrapolated from the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">NICE, 2009</a>] and the joint ESPGHAN/ESPID publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Guarino, 2014</a>], and based on the PHE publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2015</a>] and WGO expert consensus guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>]. It is also pragmatic, based on what CKS considers to be good clinical practice, as the person may need intravenous fluids if there is suspected or confirmed shock.</li><li>The recommendation if there is intractable vomiting or high-output diarrhoea is extrapolated from the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">NICE, 2009</a>] and the joint ESPGHAN/ESPID publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Guarino, 2014</a>], and based on the WGO expert consensus guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>].</li><li>The recommendation if there is a suspected serious complication is based on the PHE publications [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020a</a>], the IDSA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Shane, 2017</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Jones, 2009</a>]. It is also pragmatic, based on what CKS considers to be good clinical practice.</li></ul><h5>Considering arranging hospital assessment</h5><ul><li>The recommendation if there is a suspected serious alternative diagnosis is extrapolated from the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">NICE, 2009</a>], the joint ESPGHAN/ESPID publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Guarino, 2014</a>], the WGO expert consensus guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Jones, 2009</a>]. It is also pragmatic, based on what CKS considers to be good clinical practice.</li><li>The recommendation if there is an inadequate response to oral rehydration salt (ORS) solution taken orally is extrapolated from the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">NICE, 2009</a>] and the joint ESPGHAN/ESPID publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Guarino, 2014</a>], and based on the WGO expert consensus guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>] and IDSA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Shane, 2017</a>]. It is also pragmatic, based on what CKS considers to be good clinical practice.</li><li>The recommendation if there are risk factors for dehydration is based on the IDSA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Shane, 2017</a>] and WGO expert consensus guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>], and is extrapolated from expert opinion in a review article, as the person may need intravenous fluids [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Jones, 2009</a>].</li><li>The recommendation if there are concerns about the social circumstances at home is extrapolated from the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">NICE, 2009</a>] and the joint ESPGHAN/ESPID publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Guarino, 2014</a>]. It is also pragmatic, based on what CKS considers to be safe clinical practice.</li></ul><h5>Liaising with a specialist for advice if uncertainty</h5><ul><li>The recommendation on possible hospital admission is extrapolated from the PHE publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2015</a>].</li><li>The recommendation on suspected travellers' diarrhoea is based on the expert consensus publication on travellers' diarrhoea, which found moderate-quality evidence that antibiotic treatment is not recommended in people with mild symptoms, and moderate-to-high quality evidence that antibiotics should be used to treat moderate-to-severe symptoms [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Riddle, 2017</a>]. In addition, expert opinion in a review article notes that people with prolonged travellers' diarrhoea may need specialist tests [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Barrett, 2016</a>].</li></ul><!-- end field 44c74096-6d57-4e14-904f-c6391070ca3e --><!-- end item ebbcc789-2a0b-4719-89fe-703ac75daaac -->","subChapters":[]}]},{"id":"57ce3291-edf8-57da-8188-9b7835b7eaf5","slug":"management-in-primary-care","fullItemName":"Management in primary care","depth":3,"htmlHeader":"<!-- begin field 955dc239-8c37-42d0-b000-abf900937724 --><h3>How should I manage an adult with gastroenteritis in primary care?</h3><!-- end field 955dc239-8c37-42d0-b000-abf900937724 -->","summary":null,"htmlStringContent":"<!-- begin item 4b121529-0077-447c-a172-abf9009376e0 --><!-- begin field fc3cf407-b83a-4f9f-80fb-abf900937724 --><p><strong>If an adult does not need immediate hospital <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/management/adult-gastroenteritis/#hospital-admission\">admission</a>, advise on management and follow up in primary care:</strong></p><ul><li><strong>Provide advice on sources of support and information,</strong> such as:<ul><li>The patient.info leaflets <a href=\"https://patient.info/digestive-health/diarrhoea/gastroenteritis\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"20ad5178-e32f-49f9-b530-ac0f015014e2\">Gastroenteritis</a>, <a href=\"https://patient.info/digestive-health/diarrhoea/food-poisoning\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"46bccf4b-cfba-46ee-a89d-ac0f015014ee\">Food poisoning</a>, and <a href=\"https://patient.info/travel-and-vaccinations/travellers-diarrhoea-leaflet\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"3c0b8e30-89a1-45d9-b3dd-ac0f015014fa\">Traveller's diarrhoea</a>.</li><li>The NHS leaflets <a href=\"https://www.nhs.uk/conditions/diarrhoea-and-vomiting/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"e556b8a9-7804-4559-89ce-ac0f0150150b\">Diarrhoea and vomiting</a> and <a href=\"https://www.nhs.uk/conditions/food-poisoning/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"746fecba-2341-4372-a8f1-ac0f01501525\">Food poisoning</a>.</li></ul></li><li><strong>Advise on how to monitor fluid intake and prevent/treat dehydration.</strong><ul><li>In healthy adults:<ul><li>Encourage regular fluid intake, and supplement with fruit juice and soups if needed.</li></ul></li><li>In adults at increased risk of dehydration (such as the elderly, immunocompromised, those with co-morbid conditions or concurrent illness):<ul><li>Advise on the use of oral rehydration salt (ORS) solution as supplemental fluid.</li></ul></li><li>In adults with clinical features of <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/diagnosis/assessment/#assessing-for-dehydration-in-adults\">dehydration</a> who can safely be managed at home:<ul><li>Advise to use ORS solution frequently and in small amounts, such as 200–400 mL to be given after every loose motion, dose according to fluid loss, to rehydrate the person.</li></ul></li><li>After rehydration:<ul><li>Gradually reintroduce usual diet, advising that small, light, non-fatty, non-spicy meals may be better tolerated.</li></ul></li></ul></li><li><strong>Advise that drug treatment with antidiarrhoeal (or antimotility) drugs, antiemetics, and probiotics is <em>not</em> routinely recommended</strong> for use in adults in primary care.<ul><li>Antidiarrhoeal drugs may be useful for symptom relief in adults with mild-to-moderate diarrhoea, for example, if rapid resolution would enable the person to resume essential activities. Advise that they are available to purchase over-the-counter, but should <em>not</em> be used if a person has:<ul><li>Blood, mucus, and/or pus in the stools or high fever (suggesting possible dysentery).</li><li>Shigellosis or confirmed, probable, or suspected Shiga toxin-producing <em>Escherichia coli </em>0157 (STEC) infection, following <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/diagnosis/assessment/\">stool culture</a> and sensitivity testing.</li></ul></li></ul></li><li><strong>Do not routinely prescribe antibiotics to adults with gastroenteritis.</strong><ul><li>Arrange treatment of confirmed microbial pathogens, if appropriate, following <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/diagnosis/assessment/\">stool culture</a> and sensitivity testing. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/management/adult-gastroenteritis/#management-of-confirmed-cause\">Management of confirmed cause</a> for more information.</li></ul></li><li><strong>Advise on methods to prevent transmission of infection:</strong><ul><li>Wash hands thoroughly with liquid soap in warm running water, and dry carefully.</li><li>Always use a flush toilet, if possible.<ul><li>If a commode or bedpan must be used, it should be handled with gloves, the contents disposed of into the toilet, and the container then washed with hot water and detergent and allowed to dry.</li><li>Wash hands after going to the toilet and changing nappies, and before preparing, serving, or eating food.</li><li>Toilet seats, flush handles, wash-hand basin taps, surfaces, and toilet door handles should be cleaned at least once daily with hot water and detergent. A disinfectant and disposable cloth (or one dedicated for toilet use) should be used to clean toilets.</li></ul></li><li>Do not share towels and flannels used by the infected person.</li><li>Wash soiled clothing and bed linen separately from other clothes and at a high temperature (for example 60°C or higher for cotton), after removal of excess faecal matter or vomitus into the toilet. Soaking in disinfectant is not necessary. The washing machine should not be more than half full to allow for adequate washing and rinsing.</li><li>The PHE leaflet <a href=\"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/861382/management_of_gastrointestinal_infections.pdf#page=82\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"fe252e61-8dee-49fa-8bee-abfe00afadd8\">Minimising the spread of gastrointestinal infection</a> provides detailed information on personal hygiene, environmental cleaning, and disposal of soiled materials.</li></ul></li><li><strong>Advise that the person should not attend work or other institutional/social settings until at least 48 hours after the last episode of diarrhoea or vomiting.</strong><ul><li>Note: for some gastrointestinal infections, longer periods of exclusion are needed, and 'microbiological clearance' with negative stool testing may be required before return to specific settings. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/management/adult-gastroenteritis/#management-of-confirmed-cause\">Management of confirmed cause</a> for more information.</li><li>Note: if <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/causes/#parasites\">cryptosporidiosis</a> or <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/causes/#parasites\">giardiasis</a> is suspected or confirmed, the person should not go swimming for 2 weeks after the last episode of diarrhoea.</li></ul></li><li><strong>Advise the person/carers on the need for follow up and to seek urgent medical advice if there are:</strong><ul><li>Any features requiring hospital admission or assessment. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/management/adult-gastroenteritis/#hospital-admission\">Hospital admission</a> for more information.</li><li>Any new features requiring <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/diagnosis/assessment/\">stool culture</a> testing, such as blood, mucus, and/or pus in the stool (suggesting possible dysentery).</li><li>Symptoms that do not resolve within the expected timeframe, such as diarrhoea that has not resolved by day 7 —  arrange <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/diagnosis/assessment/\">stool culture</a> testing and consider whether an <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/diagnosis/differential-diagnosis/\">alternative diagnosis</a> is possible.</li></ul></li><li><strong>Notify the <a href=\"https://www.gov.uk/health-protection-team\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"09ee5924-4988-4495-ac62-ac0e0160e26d\">local health protection team</a> immediately by completing a <a href=\"https://www.gov.uk/government/publications/notifiable-diseases-form-for-registered-medical-practitioners\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"096b48e8-18e8-46b3-9f4f-ac0e01605e15\">notification form</a>, if any of the following notifiable diseases or <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/causes/\">organisms</a> is <em>suspected</em>:</strong><ul><li>Food poisoning (such as suspected <em>Bacillus cereus</em>, <em>Campylobacter</em> spp., <em>Clostridium perfringens</em>, <em>Cryptosporidium </em>spp., <em>Entamoeba histolytica</em>, verocytotoxigenic <em>Escherichia coli </em>(including <em>E. coli</em> O157:H7), <em>Salmonella </em>spp., <em>Giardia lamblia</em>, and <em>Yersinia pestis</em>), including suspected clusters or outbreaks.</li><li>Haemolytic uraemic syndrome.</li><li>Infectious bloody diarrhoea, such as <em>Shigella</em> spp.</li><li>Enteric fever (typhoid or paratyphoid fever).</li><li>Cholera.</li></ul></li></ul><!-- end field fc3cf407-b83a-4f9f-80fb-abf900937724 --><!-- end item 4b121529-0077-447c-a172-abf9009376e0 -->","subChapters":[{"id":"49af0692-5413-5e77-89be-7c0cb67a2fd3","slug":"basis-for-recommendation-c1d","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f6e271e4-34af-44dc-a551-abf900937729 --><h4>Basis for recommendation</h4><!-- end field f6e271e4-34af-44dc-a551-abf900937729 -->","summary":null,"htmlStringContent":"<!-- begin item c1d6df12-2196-4030-93f9-abf900937729 --><!-- begin field 570c3d25-a2b4-4005-a3ec-abf900937729 --><p>The recommendations on management are extrapolated from the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Diarrhoea and vomiting caused by gastroenteritis: diagnosis, assessment, and management in children younger than 5 years</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">National Collaborating Centre for Women's and Children's Health, 2009</a>], and largely based on the Public Health England (PHE) publications <em>Recommendations for the public health management of gastrointestinal infections 2019. Principles and practice</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020a</a>] and <em>Notifiable diseases and causative organisms: how to report</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020b</a>]; the World Gastroenterology Organisation (WGO) global guidelines <em>Acute diarrhea in adults and children: a global perspective</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>]; the Cochrane systematic reviews <em>Hand washing promotion for preventing diarrhoea</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Ejemot-Nwadiaro, 2015</a>] and <em>Probiotics for treating acute infectious diarrhoea</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Allen, 2010</a>]; the American College of Gastroenterology (ACG) clinical guideline <em>Diagnosis, treatment, and prevention of acute diarrheal infections in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Riddle, 2016</a>]; the Infectious Diseases Society of America (IDSA) publication <em>Clinical practice guidelines for the diagnosis and management of infectious diarrhea</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Shane, 2017</a>]; the expert consensus publication <em>Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Riddle, 2017</a>]; and expert opinion in a review article on acute diarrhoea in adults [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Jones, 2009</a>] and on travellers' diarrhoea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Barrett, 2016</a>].</p><h5>Advising on fluid intake and management of dehydration</h5><ul><li>These recommendations are largely based on the WGO global guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>], the ACG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Riddle, 2016</a>], the IDSA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Shane, 2017</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Barrett, 2016</a>].<ul><li>The information on the possible use of fruit juice and soups as supplemental fluid is based on moderate-quality evidence in the ACG guideline, which notes that 'most individuals with acute diarrhoea or gastroenteritis can keep up with fluids and salt by consumption of water, juices, sports drinks, soups, and saltine crackers'. This approach is supported by expert opinion in a review article on travellers' diarrhoea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Barrett, 2016</a>], and is consistent with the expert opinion of previous external reviewers of this CKS topic.</li><li>The WGO expert consensus guidelines note that oral rehydration therapy (ORT) is a cost-effective method of managing acute gastroenteritis that reduces the need for hospitalization in both developed and developing countries. Low-osmolarity oral rehydration salt (ORS) solution has reduced concentrations of sodium and glucose, and is associated with less vomiting, stool output, hypernatraemia, and reduced need for intravenous fluids compared with standard ORS. It noted that fruit juices are hyperosmolar and can worsen diarrhoea symptoms.</li><li>Similarly, the IDSA publication found moderate-quality evidence supporting the use of low-osmolarity ORS as first-line therapy of mild-to-moderate dehydration due to acute diarrhoea and vomiting. CKS notes it also does not recommend the use of fruit juices for rehydration.</li><li>The recommended doses of ORS solution to use for rehydration are based on expert opinion in the British National Formulary (BNF) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Joint Formulary Committee, 2020</a>].</li><li>The recommendation on gradually restarting usual diet is based on the IDSA publication, which found low-quality evidence that usual diet should be resumed during or immediately after rehydration, and the WGO guidelines, which state that withholding food for more than 4 hours is inappropriate. It is also pragmatic, based on what CKS considers to be sensible clinical practice.</li></ul></li></ul><h5>Advising on the possible use of loperamide for symptom relief</h5><ul><li>These recommendations are based on the WGO global guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>], the ACG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Riddle, 2016</a>], the IDSA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Shane, 2017</a>], an expert consensus guideline on travellers' diarrhoea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Riddle, 2017</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Barrett, 2016</a>].<ul><li>The WGO expert consensus guidelines note that anti-diarrhoeal drugs do not address the underlying causes or effects of diarrhoea, such as loss of water, electrolytes, and nutrients. It recommends that loperamide may be used for mild-to-moderate travellers' diarrhoea. It found inadequate evidence to support the use of absorbents such as kaolin for acute diarrhoea in adults.</li><li>The IDSA publication found moderate-quality evidence supporting the use of loperamide for immunocompetent adults with acute, watery diarrhoea.</li><li>The guideline on travellers' diarrhoea found moderate-quality evidence for the use of loperamide for the treatment of mild symptoms, and high-quality evidence for the use of loperamide for moderate symptoms. Similarly, the ACG guideline found moderate-quality evidence that loperamide may be used in combination with antibiotic therapy for people with travellers' diarrhoea, to decrease the duration of symptoms and increase the chance of cure. Expert opinion in a review article also recommends the use of anti-diarrhoeal drugs if rapid resolution of travellers' diarrhoea is needed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Barrett, 2016</a>].</li><li>The information on when loperamide should not be used is based on the WGO guidelines, the IDSA publication, expert opinion in a review article that notes that severe abdominal pain or bloody diarrhoea can be a sign of colitis and risk of intestinal perforation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Barrett, 2016</a>], and expert opinion in the BNF [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Joint Formulary Committee, 2020</a>].</li></ul></li></ul><h5>Drug treatments not routinely recommended in primary care</h5><ul><li>The recommendation on antiemetics is based on very limited evidence from the WGO global guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>] and the IDSA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Shane, 2017</a>]. CKS notes the lack of trial evidence on the use of antiemetics for acute gastroenteritis in adults.<ul><li>The WGO expert consensus guidelines note that antiemetics are usually unnecessary for the management of acute diarrhoea, and some drugs have sedative adverse effects that may make the use of ORT challenging.</li><li>The IDSA publication notes that the use of antiemetic drugs is not a substitute for fluid and electrolyte therapy, but their use may be considered once the person is adequately rehydrated.</li></ul></li><li>The recommendation on probiotics is based on a Cochrane systematic review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Allen, 2010</a>], the IDSA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Shane, 2017</a>], the ACG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Riddle, 2016</a>], and the expert consensus publication on travellers' diarrhoea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Riddle, 2017</a>].<ul><li>A Cochrane systematic review of 63 variable-quality randomized controlled trials (RCTs, n = 8014) of the effects of probiotics for treating proven or presumed acute infectious diarrhoea in children and adults found:<ul><li>Probiotics reduced the duration of diarrhoea with a mean difference in duration of diarrhoea of 24.76 hours (95% CI 15.9 to 33.6 hours); a reduced likelihood of diarrhoea duration for more than 4 days (risk ratio 0.41; CI 0.32 to 0.53); and reduced stool frequency on day 2 (mean difference 0.80; CI 0.45 to 1.14). There were considerable differences in effect size between the studies, and significant heterogeneity in the study populations and settings, definitions of diarrhoea illness, pathogens, and probiotic strains and doses used.</li><li>The authors concluded that probiotics appear to be safe and beneficial, but more research is needed to guide the use of particular probiotic regimens in specific patient groups. In addition, CKS notes the limited generalizability of the findings to adults, as 56 of the 63 included studies examined infants and young children specifically.</li></ul></li><li>The IDSA publication reported on trial evidence on probiotics that showed a decrease in diarrhoea duration and stool frequency with a 'sustained beneficial effect across all outcomes', however, the results of studies were limited by statistical heterogeneity owing to varying definitions of diarrhoea, outcome measurements, probiotic product, treatment regimens, study participants, and settings.</li><li>The ACG clinical guideline found moderate-quality evidence to not support the use of probiotics or prebiotics for treatment of acute diarrhoea in adults, except in cases of post-antibiotic associated illness.</li><li>The expert consensus guideline on travellers' diarrhoea made an ungraded recommendation that there is insufficient evidence to recommend the use of commercially available prebiotics or probiotics to prevent or treat travellers’ diarrhoea.</li></ul></li></ul><h5>Antibiotic treatment not routinely recommended in primary care</h5><ul><li>This recommendation is based on limited evidence from the ACG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Riddle, 2016</a>], and is extrapolated from the NICE clinical guideline on gastroenteritis in children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">NICE, 2009</a>], in the absence of other good-quality evidence.<ul><li>The ACG guideline found very low-quality evidence to not support the empirical use of antibiotics for community-acquired diarrhoea, as epidemiological studies suggest this is largely viral in origin, and diarrhoea symptoms are not shortened by the use of antibiotics.</li><li>The NICE clinical guideline noted weak, conflicting evidence from RCTs that empirical antibiotics may reduce the duration of diarrhoea, however, this was not felt to be relevant in UK settings, as the range of causative microorganisms commonly responsible for gastroenteritis in children were unlikely to respond to empirical antibiotic treatment.</li><li>In addition, this recommendation is pragmatic, based on what CKS considers to be good clinical practice, taking into account potential adverse effects of antibiotic treatment and the risk of increasing bacterial resistance with empirical use.</li></ul></li></ul><h5>Advising on methods to prevent infection transmission</h5><ul><li>These recommendations are largely based on a PHE publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020a</a>], a Cochrane systematic review on handwashing [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Ejemot-Nwadiaro, 2015</a>], and the IDSA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Shane, 2017</a>].<ul><li>The PHE publication notes that transmission of gastrointestinal infection from person-to-person may occur through a variety of different pathways, including faecal-oral, foodborne, environmental, and airborne routes.</li><li>A Cochrane systematic review of 22 RCTs on the effects of handwashing compared with no intervention for the prevention of diarrhoea in children and adults found:<ul><li>High-quality evidence from nine studies (n = 4664) that handwashing education and sometimes soap provision in childcare facilities and schools in high-income countries prevented about one-third of diarrhoea episodes (rate ratio 0.70; 95% CI 0.58 to 0.85).</li></ul></li><li>The IDSA publication recommends a range of hand hygiene and infection control measures, to reduce the risk of transmission of acute infectious diarrhoea to others.</li></ul></li></ul><h5>Advising on exclusion from work and other institutional/social settings</h5><ul><li>These recommendations are largely based on a PHE publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020a</a>]. <ul><li>All people with gastroenteritis should be considered as potentially infectious to others, and excluded from work, school, or other institutional/social settings until a minimum of 48 hours symptom-free or with no loose stools. The document also gives detailed information on the need for longer periods of exclusion and 'microbiological clearance' in some circumstances.</li><li>The information on exclusion from swimming is based on the fact that <em>Cryptosporidium</em> outbreaks have been associated with public and private water supplies and swimming pools, and <em>Giardia </em>cysts continue to be shed after symptoms have stopped. Both pathogens are resistant to normal chlorine levels used in swimming pools, with potential to contaminate the pool environment and cause onward transmission.</li></ul></li></ul><h5>Giving safety-netting advice on follow up and review</h5><ul><li>These recommendations are based on the WGO global guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>], the ACG clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Riddle, 2016</a>], the IDSA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Shane, 2017</a>], expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Jones, 2009</a>], and are also pragmatic, based on what CKS considers to be good clinical practice.<ul><li>The WGO expert consensus guidelines highlight the importance of carers being able to recognize features of dehydration (in children) and when to seek medical help.</li><li>The recommendation on the need for review if there are new clinical features such as possible dysentery is based on the WGO expert consensus guidelines, the ACG guideline, and moderate-quality evidence in the IDSA publication.</li><li>The recommendation on the need for clinical reassessment if symptoms persist for longer than expected is based on expert opinion in a review article, which notes that a decision to arrange review depends on the natural history of symptoms. Diarrhoea that has not resolved by day 7 needs investigation to identify persistent infectious or non-infectious causes, and ongoing symptoms after microorganisms have been identified and treated may indicate other gastrointestinal disorders or alternative diagnoses [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Jones, 2009</a>]. This approach is supported by very low-quality evidence cited in the ACG clinical guideline, which recommends further investigation if symptoms persist beyond 7 days, in order to identify the cause and arrange treatment, if appropriate.</li></ul></li></ul><h5>Ensuring notification of relevant diseases and organisms</h5><ul><li>These recommendations are based on a PHE publication on notification, which states that depending on the specific microorganism identified, testing of symptomatic and asymptomatic household, co-traveller, and sexual contacts may be needed. In addition, in some cases, repeat stool sample testing 1 week after treatment completion may be needed to confirm treatment success [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020b</a>].</li></ul><!-- end field 570c3d25-a2b4-4005-a3ec-abf900937729 --><!-- end item c1d6df12-2196-4030-93f9-abf900937729 -->","subChapters":[]}]},{"id":"3feedee9-e22e-5afc-930e-852ac1d35ff6","slug":"management-of-confirmed-cause","fullItemName":"Management of confirmed cause","depth":3,"htmlHeader":"<!-- begin field 7715d884-8d2f-4416-a2f9-d06a4af405e2 --><h3>How should I manage gastroenteritis due to a confirmed microbiological cause?</h3><!-- end field 7715d884-8d2f-4416-a2f9-d06a4af405e2 -->","summary":null,"htmlStringContent":"<!-- begin item dab4b674-cddf-4054-b3fe-37a8014f6a73 --><!-- begin field 99a3112f-7cb3-4eb4-948f-abf9009643a1 --><p><strong>If an adult with gastroenteritis has a specific microbiological cause confirmed after <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/diagnosis/assessment/\">stool culture</a> and sensitivity testing:</strong></p><ul><li><strong>Seek advice from the <a href=\"https://www.gov.uk/health-protection-team\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"f071c6b0-deb5-449d-9cb6-ac1001174527\">local health protection team</a> regarding the need for antibiotic treatment or stool testing for microbiological clearance, if there is any uncertainty:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/causes/#bacteria\">Campylobacteriosis</a><ul><li>Antibiotic treatment is not usually needed for people with mild symptoms, as infection is usually self-limiting.</li><li>If symptoms are severe (high fever, bloody and/or high-output diarrhoea) or the person is immunocompromised, consider early prescribing with clarithromycin 250–500 mg twice daily for 5–7 days, within 3 days of onset of illness. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/prescribing-information/clarithromycin/\">Clarithromycin</a> in <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/prescribing-information/\">Prescribing information</a> for more information.</li></ul></li><li><a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/causes/#parasites\">Cryptosporidiosis</a><ul><li>There is no specific treatment licensed in the UK.</li><li>Seek specialist advice if the person is severely immunocompromised, owing to the risk of serious and life-threatening <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/complications/\">complications</a>.</li></ul></li><li><a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/causes/#parasites\">Amoebiasis or amoebic dysentery</a><ul><li>Drug treatment is usually recommended for all confirmed cases after specialist advice, such as metronidazole followed by the anti-protozoal drug diloxanide.</li><li>Seek specialist advice regarding the need for microbiological clearance to confirm treatment success, 1 week after completing treatment.</li></ul></li><li><a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/causes/#bacteria\">Escherichia coli (E. coli)</a><ul><li>There is no effective antibiotic treatment available for Shiga toxin-producing <em>E. coli</em> (STEC) infection.</li><li>Seek specialist advice on the need for stool testing for microbiological clearance in people at <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/diagnosis/assessment/\">increased risk of transmission</a> of infection, if there is confirmed STEC infection — two consecutive negative stool samples are usually needed taken at least 24 hours apart, once the person is symptom free for at least 48 hours, before the person can return to work or other institutional/social settings.</li><li>Seek specialist advice if there is confirmed STEC infection regarding monitoring for the complication of <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/complications/\">haemolytic uraemic syndrome</a>.</li><li>Seek specialist advice regarding the need for exclusion and microbiological clearance in non-STEC infection in people at increased risk of transmission of infection, such as food handlers — two consecutive negative stool samples are usually needed, the second sample taken 48 hours after the person is symptom free, before the person can return to work, depending on a risk assessment.</li></ul></li><li><a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/causes/#parasites\">Giardiasis</a><ul><li>Prescribe tinidazole 2 g as a single dose. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/prescribing-information/tinidazole/\">Tinidazole</a> in <a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/prescribing-information/\">Prescribing information</a> for more information.</li></ul></li><li><a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/causes/#bacteria\">Salmonellosis (non-typhoidal)</a><ul><li>Antibiotic treatment is not usually needed.</li></ul></li><li><a class=\"topic-reference internal-reference\" href=\"/topics/gastroenteritis/background-information/causes/#bacteria\">Shigellosis</a><ul><li>Antibiotic treatment is not usually needed for people with mild symptoms.</li><li>If symptoms are severe (high fever, bloody and/or high-output diarrhoea) or the person is immunocompromised, seek specialist advice on the need for antibiotic treatment.</li><li>Advise on safe sexual practices if transmission amongst men who have sex with men has resulted in an outbreak.</li><li>Seek specialist advice on the need for exclusion of cases from childcare or work settings, and the need for microbiological clearance stool testing, which varies depending on the <em>Shigella</em> species.</li></ul></li></ul></li></ul><!-- end field 99a3112f-7cb3-4eb4-948f-abf9009643a1 --><!-- end item dab4b674-cddf-4054-b3fe-37a8014f6a73 -->","subChapters":[{"id":"3a92d350-8335-5610-991b-d0b5cec624ad","slug":"basis-for-recommendation-0b2","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 99f3ed5e-5f27-4d40-9918-abf90147a0a9 --><h4>Basis for recommendation</h4><!-- end field 99f3ed5e-5f27-4d40-9918-abf90147a0a9 -->","summary":null,"htmlStringContent":"<!-- begin item 0b2f0c64-6beb-4a5e-aa1f-abf90147a068 --><!-- begin field 601caa06-2a6d-4303-913e-abf90147a0a9 --><p>The recommendations on management of specific confirmed infections are largely based on the National Institute for Health and Care Excellence (NICE) and Public Health England (PHE) joint publication <em>Summary of antimicrobial prescribing guidance - managing common infections</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">NICE, 2020</a>]; the NICE surveillance review <em>2018 surveillance of diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">NICE, 2018</a>]; the PHE publications <em>Managing suspected infectious diarrhoea. Quick reference guidance for primary care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2015</a>], <em>Shiga toxin-producing Escherichia coli (STEC): symptoms, how to avoid, how to treat</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2017</a>], <em>Health protection in schools and other childcare facilities</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2019</a>], and <em>Recommendations for the public health management of gastrointestinal infections 2019. Principles and practice</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020a</a>]; the World Gastroenterology Organisation (WGO) global guidelines <em>Acute diarrhea in adults and children: a global perspective</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>]; and the expert consensus publication <em>Guidelines for the prevention and treatment of travellers' diarrhea: a graded expert panel report</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Riddle, 2017</a>].</p><ul><li>The recommendations on campylobacteriosis are based on the PHE publication on gastrointestinal infections [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020a</a>] and the joint NICE/PHE publication on antimicrobial prescribing [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">NICE, 2020</a>].</li><li>The recommendations on cryptosporidiosis are based on the PHE publication on gastrointestinal infections [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020a</a>].</li><li>The recommendations on amoebiasis are based on the PHE publication on gastrointestinal infections [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020a</a>] and the WGO expert consensus guidelines, which note that the choice of antimicrobial treatment should be based on the susceptibility patterns of strains of the pathogens in the locality/region [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Farthing, 2012</a>].</li><li>The recommendations on Shiga toxin-producing <em>Escherichia coli</em> (STEC) infection and non-STEC infection including the need for exclusion and microbiological clearance testing in certain risk groups are based on the PHE publication on gastrointestinal infections [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020a</a>], together with the PHE publications on STEC [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2017</a>] and on schools and childcare facilities [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2019</a>]. In addition, the use of antibiotics in STEC infection increases the risk of haemolytic uraemic syndrome (HUS) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2015</a>]. The information on the need for specialist monitoring for complications such as HUS is extrapolated from the NICE surveillance review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">NICE, 2018</a>].</li><li>The recommendations on giardiasis are based on the joint NICE/PHE publication on antimicrobial prescribing [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">NICE, 2020</a>] and the British National Formulary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">Joint Formulary Committee, 2020</a>].</li><li>The recommendations on salmonellosis are based on the PHE publication on gastrointestinal infections [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020a</a>].</li><li>The recommendations on shigellosis including the need for exclusion and microbiological clearance testing in certain risk groups are based on the PHE publications on gastrointestinal infections [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2020a</a>] and on schools and childcare facilities [<a class=\"bibliography-reference internal-reference\" href=\"/topics/gastroenteritis/references/\">PHE, 2019</a>].</li></ul><!-- end field 601caa06-2a6d-4303-913e-abf90147a0a9 --><!-- end item 0b2f0c64-6beb-4a5e-aa1f-abf90147a068 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}